ARCH Venture Fund X, L.P.'s Net Worth

$638 Million

Who is ARCH Venture Fund X, L.P.?

ARCH Venture Fund X, L.P. has an estimated net worth of $638 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Neumora Therapeutics, Inc., Erasca, Inc., Verve Therapeutics, Inc., and Prime Medicine, Inc..

SEC CIK

ARCH Venture Fund X, L.P.'s CIK is 0001757011

Past Insider Trading and Trends

2021 was ARCH Venture Fund X, L.P.'s most active year for acquiring shares with 12 total transactions. ARCH Venture Fund X, L.P.'s most active month to acquire stocks was the month of January. 2021 was ARCH Venture Fund X, L.P.'s most active year for disposing of shares, totalling 30 transactions. ARCH Venture Fund X, L.P.'s most active month to dispose stocks was the month of January. 2023 saw ARCH Venture Fund X, L.P. paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2022 ARCH Venture Fund X, L.P. cashed out on 35,616,279 shares for a total of $0.00, their largest year based on trade value.